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Abstract
Objective To determine whether, from a health provider and
patient perspective, surgical stabilisation of the spine is cost
effective when compared with an intensive programme of
rehabilitation in patients with chronic low back pain.
Design Economic evaluation alongside a pragmatic
randomised controlled trial.
Setting Secondary care.
Participants 349 patients randomised to surgery (n = 176) or to
an intensive rehabilitation programme (n = 173) from 15
centres across the United Kingdom between June 1996 and
February 2002.
Main outcome measures Costs related to back pain and
incurred by the NHS and patients up to 24 months after
randomisation. Return to paid employment and total hours
worked. Patient utility as estimated by using the EuroQol
EQ-5D questionnaire at several time points and used to
calculate quality adjusted life years (QALYs). Cost effectiveness
was expressed as an incremental cost per QALY.
Results At two years, 38 patients randomised to rehabilitation
had received rehabilitation and surgery whereas just seven
surgery patients had received both treatments. The mean total
cost per patient was estimated to be £7830 (SD £5202) in the
surgery group and £4526 (SD £4155) in the intensive
rehabilitation arm, a significant difference of £3304 (95%
confidence interval £2317 to £4291). Mean QALYs over the
trial period were 1.004 (SD 0.405) in the surgery group and
0.936 (SD 0.431) in the intensive rehabilitation group, giving a
non-significant difference of 0.068 ( − 0.020 to 0.156). The
incremental cost effectiveness ratio was estimated to be £48 588
per QALY gained ( − £279 883 to £372 406).
Conclusion Two year follow-up data show that surgical
stabilisation of the spine may not be a cost effective use of
scarce healthcare resources. However, sensitivity analyses show
that this could change—for example, if the proportion of
rehabilitation patients requiring subsequent surgery continues
to increase.
Introduction
Chronic low back pain, defined as pain lasting for more than
three months, is common and places a major economic burden
on individuals, the healthcare system, and society as a whole.
Direct costs associated with the disability were estimated to be
around £1.6bn in the United Kingdom in 1998,1 and the condi-
tion is estimated to be responsible for close to 120 million UK
work days lost per year.2
The optimal treatment strategy for patients with chronic low
back pain in whom conservative therapy has failed remains
uncertain. For three trials, the results of randomised compari-
sons between surgical and conservative management techniques
have been published.3–5 Evidence from these trials shows that
surgery may have some clinical benefit, but it is not clear whether
intensive rehabilitation in conjunction with cognitive educa-
tional programmes can generate similar benefits for patients.
Results from the first UK based trial, the spine stabilisation trial,
show a significant difference in the Oswestry disability index at
two years in patients randomised to spinal fusion surgery
compared with intensive rehabilitation, which is arguably of
clinical importance.6 This statistical difference between treatment
groups in only one of the two primary outcome measures was
marginal and only just reached the predefined minimal clinical
difference. The potential risk and additional cost of surgery also
need to be considered. No clear evidence emerged that primary
fusion was any more beneficial than intensive rehabilitation. We
report an economic evaluation conducted prospectively
alongside the UK spine stabilisation trial. We employ a cost util-
ity framework to determine whether any net health gain from
using surgery would be sufficient to justify a likely increase in the
costs of treatment. The chosen form of analysis will facilitate
comparisons between the cost effectiveness of surgery and that
of other healthcare interventions competing for healthcare
resources.
Methods
Full details of the randomised controlled trial are published in
parallel with this paper.6 Briefly, the trial was powered to detect a
four point difference on the Oswestry disability index (a
questionnaire designed to assess limitations of various activities
of daily living7 8) between surgery and intensive rehabilitation at
24 months. We recruited 349 patients who met trial eligibility
criteria from 15 centres around the UK between June 1996 and
Additional details of the costing method, the participating units, and the
members of the MRC steering committee are on bmj.com
Cite this article as: BMJ, doi:10.1136/bmj.38441.429618.BF (published 23 May 2005)
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February 2002. Of these patients, 176 were randomised to spinal
fusion surgery and 173 to intensive rehabilitation.
For surgery patients, the local operating surgeon decided the
type of spinal stabilisation used. Rehabilitation patients attended
a paced exercise and education programme based on principles
of cognitive behaviour therapy totalling about 75 hoursl. We fol-
lowed patients and collected back pain related NHS data and
data on use of resources by patients to 24 months after randomi-
sation. Patients who considered that their allocated treatment for
chronic low back pain had failed could have further treatment
including surgery. At baseline, six, 12, and 24 months, patients
completed the EuroQol EQ-5D questionnaire, a generic health
outcome instrument used to estimate utility scores9 and quality
adjusted life years (QALYs).
Resource use
Patient specific data on the use of NHS resources included initial
treatments, other back pain related hospital inpatient and outpa-
tient visits, primary care contacts, and prescribed items of medi-
cation. We also collected data on over the counter medications
purchased and visits made to private practitioners. The number
of centres participating in the trial and constraints on resources
precluded the collection of centre specific unit costs. Unless oth-
erwise indicated, we used national average unit costs. All costs
calculated are expressed in 2002-3 pounds sterling, inflated to
this base year where appropriate.10
Spinal fusion surgery
A “micro” approach to the costing of surgery used patient
specific data itemised by use of resources. We costed duration
spent by each patient in the operating theatre to allow for the
time of staff involved and use of the theatre.10 11 We used unit
costs obtained from the lead investigating centre to value types
and numbers of surgical implants and intraoperative spinal x
rays.
We calculated costs for anaesthetic agents and blood
products administered during each patient’s surgery.12 We
assumed that the costs of any surgical complications were
reflected in the time spent by the patient in theatre. Finally, we
costed each patient’s surgery related inpatient stay in hospital.13
Intensive rehabilitation
For each patient, we collected information on the number of half
day rehabilitation sessions attended and applied staff costs per
session.10 Patients had one hydrotherapy session per day, valued
by using a unit cost from the lead investigating centre. We costed
exercise equipment and use of the hospital gym and a meeting
room, by adding 15% (the overhead rate employed by the lead
investigating centre) to staff, hydrotherapy, and equipment costs.
Finally, we costed overnight accommodation at either a private
bed and breakfast (paid for by the NHS) or on a hospital ward.14
Other back pain related NHS contacts
Patients reported attendances at hospital outpatient clinics for
spinal surgery, physiotherapy, and other back pain related care at
six, 12, and 24 months, which we then costed.10 13 15 16 We used the
mean cost of the initial fusion procedures (calculated as
described above) to cost hospital admissions for unplanned spi-
nal fusion surgeries. Admissions for investigations included the
cost of the evaluative procedure (provided by the lead investigat-
ing centre) plus overnight hotel costs on a general medical
ward.14 We costed visits to and home visits from general
practitioners and practice nurses.10 We used the average cost of a
rehabilitation programme (calculated as described above) to cost
any additional intensive rehabilitation.
Patients’ costs
Patients reported contacts with private complementary practi-
tioners, for which we obtained costs from relevant national
organisations. Patients also documented items of medication
prescribed, and the cost of over the counter medication
purchased for back pain (see bmj.com for more details of costing
methods).
Paid employment
Patients reported their employment status, occupation, and
hours worked at baseline, six, 12, and 24 months. We calculated
and costed total hours worked by each patient.17
Health related quality of life and quality adjusted life years
We used the EuroQol EQ-5D social tariff, estimated from a rep-
resentative sample of the UK population, to convert patients’
responses to the EuroQol EQ-5D questionnaire at baseline, six,
12, and 24 months into single utility levels.18 We then constructed
patient specific utility profiles, assuming a straight line relation
between each of the patient’s utility levels. We calculated the
number of QALYs experienced by each patient from baseline to
24 months as the area beneath this profile.
Discounting
We discounted costs and effects at an annual rate of 3.5%.19
Statistical analysis
A small amount of trial data (12% of follow-up resource use
items, 10% of utility scores, and 14% of work status data) were
missing between baseline and 24 months. We used multiple
imputation,20 which replaces each missing value with a set of m
plausible values, to generate three replacement values (m = 3) for
each of the missing cells in these datasets, using multiple linear
regression models containing the covariates intervention group,
age, and sex. Arithmetic means presented for resource use, costs,
and QALYs in each trial arm are an average of the means from
the three datasets created. Associated standard deviations
include a variance correction factor to account for variability as a
result of the imputation process.
Arithmetic means and 95% confidence intervals are
presented when making cost and QALY comparisons between
the two arms of the trial. Skewness in cost data was modest, and
we therefore report conventional parametric confidence
intervals.
We carried out incremental analysis, with the mean cost dif-
ference between surgery and rehabilitation divided by the mean
QALY difference to give the incremental cost effectiveness ratio
(ICER). The non-parametric percentile method21 for calculating
the confidence interval around this ratio used 1000 bootstrap
estimates of the mean cost and QALY differences. We used the
cost effectiveness acceptability curve to show the probability that
surgery is cost effective at two years for different values of the
NHS’s willingness to pay for an additional QALY.22
Results
Baseline patient characteristics are summarised in table 1 and
reported in detail in the companion paper.6
Resource use and costs: initial interventions
Surgery—Spinal stabilisation was carried out for 139/176
(79%) patients randomised to surgery. Procedures were divided
into three different groups: posterolateral fusion (n = 57), 360°
fusion (n = 57), and Graf stabilisation (n = 25). Table 2 presents
data on use of surgical resources and cost, averaged across all
139 patients who had surgery. The mean total cost of a spinal
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operation was estimated at £7610 (SD £2643). Zero surgery costs
were assigned to the 37 patients who did not have spinal fusion
and an average treatment cost of £6011 (SD £3896) calculated
across all surgery patients.
Intensive rehabilitation—151/173 (87%) of the patients
randomised to intensive rehabilitation attended some propor-
tion of their programme. Table 2 shows a breakdown of the
mean total cost of intensive rehabilitation among the 151
patients who attended rehabilitation. The total cost was
estimated to be £1615 (SD £644). Including zero rehabilitation
programme costs for the 22 patients who did not attend, averag-
ing across all 173 patients generated a cost estimate of £1410
(SD £808).
Intensive rehabilitation was substantially less costly than surgery
(cost difference £4601, 95% confidence interval £4013 to £5189,
P < 0.001).
Other back pain related NHS costs
Forty eight patients randomised to rehabilitation underwent sur-
gical stabilisation of the spine—10 instead of rehabilitation, 38 in
addition to rehabilitation. Table 3 shows that these unplanned
surgery costs averaged £2128 per patient across the rehabilita-
tion group. This was greater than the corresponding cost of £451
in the surgery group, which was primarily attributable to 11
patients who required spinal re-operations.
Fourteen surgery patients underwent unplanned intensive
rehabilitation (seven instead of surgery, seven as well as surgery).
These costs amounted to £162 per patient. The overall mean
cost per patient of follow-up back pain related NHS contacts was
£1302 lower in the surgery group (95% confidence interval
− £1999 to − £605, P < 0.001).
Patient costs
Table 3 shows that patient costs related to back pain were similar
in both arms.
Overall costs
Table 4 shows that at two years, spinal fusion costs £7830 (SD
£5202), and intensive rehabilitation £4526 (SD £4155). The cost
difference of £3304 favoured intensive rehabilitation (£2317 to
£4291, P < 0.001).
Return to work
At baseline, 88/176 (50%) of the surgery group and 79/173
(46%) of the rehabilitation group were not in paid employment.
By 24 months, 18 of these 88 in the surgery group (20%) and 19
of the 79 in the rehabilitation group (24%) had started some
form of employment, a non-significant difference of 4% ( − 8% to
12%, P = 0.71). The mean number of days to obtaining paid
employment was 326 (SD 167) days and 323 (SD 278) days,
respectively.
The mean total number of hours worked from baseline to 24
months in the surgery group was 1678 (SD 1847) hours and in
Table 1 Patients’ demographics at baseline. Values are numbers
(percentages) of patients unless otherwise indicated
Characteristic Surgery group (n=176) Rehabilitation group (n=173)
Male 79 (44.9) 93 (53.8)
Female 97 (55.1) 80 (46.2)
Age:
<30 years 24 (13.6) 20 (11.6)
30-39 years 63 (35.8) 67 (38.7)
40-49 years 56 (31.8) 66 (38.1)
≥50 years 33 (18.8) 20 (11.6)
Median (range) duration of
back pain in years
8 (1-35) 8 (1-35)
Table 2 Breakdown of resource use and costs associated with initial treatments (in 2002-3 pounds sterling)
Resource use item
Mean (SD) resource use per patient* Mean (SD) cost per patient*
Surgery (n=139) Rehabilitation (n=151) Surgery (n=139) Rehabilitation (n=151)
Surgical stabilisation
Duration in theatre in minutes 182 (76) N/A
Costs related to theatre duration:
Cost of theatre per se £204 (£85) N/A
Cost of theatre personnel £2635 (£1409) N/A
Cost of anaesthetics† £24.07 (£29.55) N/A
Radiography‡ 0.69 (1.06) N/A £18.39 (£24.48) N/A
Surgical implants used 96%§ N/A £1703 (£1589) N/A
Blood products used 18%§ N/A £77.79 (£241) N/A
Surgery related inpatient hospital stay in
days
7.70 (3.13) N/A £2933 (£1192) N/A
Mean total cost of a surgical stabilisation
operation¶
£7610 (£2643) N/A
Intensive rehabilitation
Number of half day rehabilitation sessions
attended
N/A 26.32 (6.94)
Costs related to session attendance:
Cost of programme personnel N/A £513.79 (£135.51)
Cost of hospital gym or exercise rooms N/A £223.70 (£59)
Cost of hydrotherapy sessions N/A £526.36 (£138.82)
Accommodation required N/A 36.5%§ N/A £350.81 (£506.99)
Mean total cost of a course of intensive
rehabilitation**
N/A £1615 (£644)
Mean total cost of interventions £6011 (£3896)†† £1410 (£808)††
N/A=Not applicable.
*Calculated for 139/176 surgery patients and 151/173 rehabilitation patients receiving allocated therapy.
†Includes cost of administering and monitoring anaesthetics.
‡Includes cost of radiography plus a 30 minute allocation of radiographer time.
§Proportion of patients consuming resource.
¶Includes low cost items not shown in the table—that is, use of image intensifier and post-operative pain control costing £0.20 and £14.82 per patient, respectively.
** Includes low cost item not shown in table—that is, exercise equipment (chair and mat) at £0.74 per patient.
††Calculated across all 176 surgery patients and all 173 rehabilitation patients.
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the rehabilitation group 1707 (SD 1870) hours (difference − 29,
95% confidence interval − 419 hours to 361 hours, P = 0.89).
Corresponding gross earnings were £19 648 (SD £22 256) and
£20 034 (SD £22 564), respectively—a non-significant difference
of − £386 ( − £5088 to £4317, P = 0.87).
Utility
Figure 1 shows utility levels at baseline, six, 12, and 24 months.
We found no significant differences in utility at any of the
follow-up points. A notable difference in utility existed at
baseline (0.35 for surgery, 0.41 for rehabilitation). Adjusting for
such a difference (using a regression based approach with trial
arm and baseline score as explanatory variables) and recalculat-
ing the area under utility frontiers specific to patients produced
a mean QALY difference in favour of surgery of 0.068 ( − 0.02 to
0.156, P = 0.13;mean 1.004 (SD 0.405) for surgery and 0.936 (SD
0.431) for rehabilitation).
Cost utility
The incremental cost per QALY of using a policy of immediate
surgery was estimated to be £48 588 ( − £279 883 to £372 406).
Figure 2 shows the cost effectiveness acceptability curve. Reading
off from the curve shows that if decision makers are willing to
pay £30 000 for a QALY (the value above which the National
Institute for Clinical Excellence is less likely to accept a technol-
ogy as cost effective23), at two years, the chance that surgery will
be cost effective is less than 20%.
Sensitivity analysis
Although uncertainty surrounds several trial variables, alterna-
tive assumptions for some would not affect the baseline conclu-
sion. For example, replacing unit costs provided by the lead
investigating centre with national averages had they been
available would make little difference. Similarly, alternative
discount rates will have little effect over a two year time horizon.
We used sensitivity analysis to examine uncertainty
surrounding the use of different surgical techniques for spinal
stabilisation. Assuming any patient in the trial receiving surgery
underwent posterolateral fusion, the least costly technique at
£6170 (£5638 to £6803), reduced the total cost in the surgery
group to £6655 and in the rehabilitation group to £4252. The
Table 3 Other back pain related NHS contacts and patient costs to 24 months after randomisation (2002-3 pounds sterling)
Resource use item
Mean (SD) No per patient Mean (SD) cost per patient Mean cost difference (95%
parametric CI)Surgery (n=176) Rehabilitation (n=173) Surgery (n=176) Rehabilitation (n=173)
Other back pain related NHS contacts
Surgery related follow-up
outpatient clinics
2.87 (2.41) 1.21 (1.77) £190 (£159) £82 (£119) £108 (£78 to £137)*
Physiotherapy outpatient clinics 3.88 (7.09) 3.91 (7.60) £286 (£523) £301 (£584) −£15 (−£131 to £101)
Other back pain related outpatient
clinics
2.06 (4.33) 2.51 (6.41) £124 (£241) £121 (£224) £3 (−£46 to £52)
Unplanned hospital admissions for
spinal surgery
0.07 (0.27) 0.31 (0.50) £451 (£1881) £2128 (£3522) −£1677 (−£2271 to −£1083)*
Other back pain related hospital
admissions
0.18 (0.49) 0.07 (0.25) £130 (£910) £73 (£555) £57 (−£101 to £215)
General practitioner consultations 7.38 (9.23) 6.81 (8.49) £198 (£232) £185 (£212) £13 (−£33 to £60)
Practice nurse consultations 0.86 (2.09) 0.62 (1.84) £15 (£35) £11 (£31) £4 (−£3 to £11)
General practitioner home visits 0.69 (1.81) 0.31 (1.03) £44 (£113) £19 (£62) £24 (£5 to £43)†
Practice nurse home visits 0.61 (2.07) 0.24 (1.15) £12 (£41) £4 (£18) £8 (£2 to £15)†
Patients attending unplanned
intensive rehabilitation
14 0 £162 (£453) £0 £162 (£94 to £229)*
Prescriptions received 14.23 (27.05) 13.43 (20.26) £95 (£200) £84 (£141) £11 (−£25 to £46)
Total other back pain related NHS
contact costs
£1707 (£2451) £3009 (£4001) −£1302 (−£1999 to −£605)*
Back pain related costs to patients
Visits to complementary
practitioners
4.00 (13.19) 2.77 (11.70) £89 (£325) £92 (£501) −£3 (−£92 to £86)
Home visits from complementary
practitioners
0.19 (2.26) 0.03 (0.17) £6 (£71) £1 (£5) £5 (−£6 to £15)
Items of over the counter
medication purchased
N/A N/A £17 (£34) £14 (£36) £3 (−£4 to £11)
Total back pain related patient
costs
£112 (£350) £107 (£502) £5 (−£86 to £96)
Total back pain related follow-up
costs
£1819 (£2511) £3116 (£4120) −£1297 (−£2014 to −£580)*
N/A=Not available.
*P≤0.001.
†P<0.05.
Table 4 Summary of initial treatment and 24 month follow-up costs (2002-03 pounds sterling)
Cost category
Surgery group (n=176) Rehabilitation group (n=173)
Mean cost difference (95% parametric CI)Mean (SD) cost per patient Mean (SD) cost per patient
Initial treatment cost £6011 (£3896) £1410 (£808) £4601 (£4013 to £5189)*
Other back pain related NHS contacts at 24
months
£1707 (£2451) £3009 (£4001) −£1302 (−£1999 to −£605)*
Total NHS cost £7718 (£5138) £4419 (£4026) £3299 (£2322 to £4267)*
Back pain related patient costs at 24 months £112 (£350) £107 (£502) £5 (−£86 to £96)
Total cost of care £7830 (£5202) £4526 (£4155) £3304 (£2317 to £4291)*
*P<0.001.
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incremental cost per QALY fell to £35 338 ( − £188 876 to
£410 404). Alternatively had all patients undergone 360° fusion,
the most costly technique at £9279 (£8632 to £9917), then the
mean cost difference would have increased to £4132 (£3065 to
£5199) and the incremental cost per QALY to £60 765
( − £420 210 to £617 081).
If the difference in utility observed at 24 months (0.566 for
surgery and 0.532 for rehabilitation after adjustments for
baseline) was maintained for a further two years, the incremental
cost per QALY at four years would fall to £25 398 (£13 121 to
£75 916).
We also examined the impact of patients receiving other
treatments subsequent to their allocated therapy. At two years, 45
patients (38 in the rehabilitation group and seven in the surgery
group) had received both treatments under comparison.
Holding all else constant and assuming patients in each arm
would continue to receive both treatments in years three, four,
and five at the rates observed in years one and two, the cost dif-
ference is reduced to £1144 ( − £312 to £2600) and the cost per
QALY to £16 824 ( − £156 358 to £138 911). If the trend contin-
ued but at half the rate observed in years one and two, the excess
cost of the surgery arm at five years would fall to £2165 (£904 to
£3425) and the cost per QALY to £31 838 ( − £407 056 to
£283 783).
Discussion
A policy in which patients receive spinal fusion surgery as first
line therapy for their chronic low back pain seems not to be a
cost effective use of healthcare resources at two year follow-up
Strengths of the study
The main strength of this study lies in the pragmatic approach
adopted by the randomised controlled trial. Patients were not
denied alternative healthcare interventions for chronic pain of
the low back, and consequently the treatment patterns observed
are likely to reflect those prevailing in routine practice.
At 24 months, the numbers of patients receiving both trial
interventions differed significantly between the two arms. It is
possible that this difference will increase beyond the two year
follow-up point, and sensitivity analyses have shown that this
could substantially affect the cost effectiveness of surgery.
Our study found no significant differences in work status
measures. Employment data were available from two of the three
previously published randomised trials comparing surgical and
conservative intervention for chronic pain of the low back.3 5 The
number of patients returning to work differed between arms (in
favour of surgery) in one of these trials, but the same trial found
no significant differences in the mean number of sick days per
patient and resulting productivity costs at 24 months.5 24
This paper presents a cost utility analysis of surgery
compared with intensive rehabilitation by using principles of
cognitive behaviour therapy in the management of chronic pain
of the low back. Although other economic evaluations of
interventions for chronic low back pain have been published,24–26
only one compared operative and conservative treatment.24
Rehabilitation included in that study focused primarily on
routine physiotherapy: comparison of cost effectiveness results
between these two trials would not therefore be useful.
Conclusion
Although a policy of spinal fusion surgery as first line therapy for
chronic low back pain seems not to be a cost effective use of
healthcare resources at two year follow-up, our analyses have
shown that this conclusion could alter if the number of rehabili-
tation patients subsequently receiving surgery continues to
increase in the future.Only with further follow-up of patients can
a robust and reliable estimate of the long term cost effectiveness
of surgery compared with intensive rehabilitation in the
management of chronic low back pain be obtained.
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What is already known on this topic
An economic evaluation of surgery for chronic low back
pain that used unspecified physical therapy as the
comparator indicated that surgery may be cost effective
A small trial reported that an intensive rehabilitation
programme including cognitive behaviour therapy
produced similar clinical benefits to spinal fusion surgery0
The cost effectiveness of surgery compared with such a
programme has not been assessed
What this study adds
In the short term, compared with intensive rehabilitation,
surgical stabilisation of the spine as first line treatment for
chronic low back pain patients who have already failed
standard non-operative care seems not be cost effective
If the number of rehabilitation patients observed having
surgery continues to increase beyond two years, or the small
treatment benefit at two years continues, this conclusion
may change
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